These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2421319)
1. Interferon and 2-5A synthetase in patients with immune diseases. Preble OT; Yeh TJ; Silverman RH; Klippel JH; Straus SE; Gelmann EP Prog Clin Biol Res; 1985; 202():415-22. PubMed ID: 2421319 [No Abstract] [Full Text] [Related]
2. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome. Preble OT; Rook AH; Steis R; Silverman RH; Krause D; Quinnan GV; Masur H; Jacob J; Longo D; Gelmann EP J Infect Dis; 1985 Sep; 152(3):457-65. PubMed ID: 2993441 [TBL] [Abstract][Full Text] [Related]
3. Persistent elevation of 2-5A synthetase and prognosis in the AIDS-related complex (ARC). Read SE; LeBrocq FJ; Williams BR Prog Clin Biol Res; 1985; 202():405-13. PubMed ID: 3008172 [No Abstract] [Full Text] [Related]
4. 2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Hylton W; Cayley J; Dore C; Denman AM Ann Rheum Dis; 1986 Mar; 45(3):220-4. PubMed ID: 3954470 [TBL] [Abstract][Full Text] [Related]
5. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application. Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131 [TBL] [Abstract][Full Text] [Related]
6. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954 [TBL] [Abstract][Full Text] [Related]
7. 2-5A synthetase activity in patients with metastatic carcinoma and its response to interferon treatment. Merritt JA; Meltzer DM; Ball LA; Borden EC Prog Clin Biol Res; 1985; 202():423-30. PubMed ID: 3832076 [TBL] [Abstract][Full Text] [Related]
8. A sensitive immunoenzymometric assay for 2',5'-oligoadenylate. Detection of elevated 2',5'-oligoadenylate synthetase in human peripheral mononuclear cells. Johnston MI; Preble OT; Imai J; Jacobsen H; Torrence PF J Immunol Methods; 1983 Dec; 65(1-2):123-35. PubMed ID: 6361140 [TBL] [Abstract][Full Text] [Related]
9. Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome. Read SE; Williams BR; Coates RA; Evans WK; Fanning MM; Garvey MB; Shepherd FA J Infect Dis; 1985 Sep; 152(3):466-72. PubMed ID: 2411826 [TBL] [Abstract][Full Text] [Related]
10. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections. Schattner A; Merlin G; Bregman V; Hahn T; Levin S; Revel M; Wallach D Clin Exp Immunol; 1984 Aug; 57(2):265-70. PubMed ID: 6467673 [TBL] [Abstract][Full Text] [Related]
11. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha. Merritt JA; Borden EC; Ball LA J Interferon Res; 1985; 5(1):191-8. PubMed ID: 3989336 [TBL] [Abstract][Full Text] [Related]
13. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase. Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242 [TBL] [Abstract][Full Text] [Related]
14. The interferon/2-5A synthetase system in primary preleukaemia patients. Justesen J; Hokland P; Hokland M Prog Clin Biol Res; 1985; 202():439-47. PubMed ID: 3868780 [No Abstract] [Full Text] [Related]
15. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome. Vojdani A; Lapp CW Immunopharmacol Immunotoxicol; 1999 May; 21(2):175-202. PubMed ID: 10319275 [TBL] [Abstract][Full Text] [Related]
16. Decreased Epstein-Barr virus-induced transformation, and elevated 2-5A synthetase and RNase L activity in peripheral blood mononuclear cells from patients treated with recombinant interferon alfa 2b. Fronko GE; Suhadolnik RJ; Vonderheid EC; Karikó K; Reichenbach NL; Chavin KD; Henderson EE Biochem Biophys Res Commun; 1988 May; 153(1):448-53. PubMed ID: 2837212 [TBL] [Abstract][Full Text] [Related]
17. 2',5' oligoadenylate synthetase activity in bovine peripheral blood mononuclear cells following bovine herpesvirus type-1-induced respiratory disease: a prognostic indicator? Bielefeldt Ohmann H; Campos M; Harland R; Griebel PJ; Babiuk LA J Interferon Res; 1989 Apr; 9(2):159-66. PubMed ID: 2715670 [TBL] [Abstract][Full Text] [Related]
18. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B. Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079 [TBL] [Abstract][Full Text] [Related]